Regenxbio
RGNX
RGNX
188 hedge funds and large institutions have $1.15B invested in Regenxbio in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 59 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% less capital invested
Capital invested by funds: $1.16B → $1.15B (-$8.24M)
1.82% less ownership
Funds ownership: 83.09% → 81.26% (-1.8%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
188
Holding in Top 10
2
Calls
$3.6M
Puts
$3.43M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$6.3M | |
| 3 | +$6.27M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.43M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$13.7M | |
| 3 | -$13.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.9M |
| 5 |
JPMorgan Chase & Co
New York
|
-$9.3M |